DH Q2 results were solid, with revenue in line and adjusted EBITDA slightly ahead. The company's near-term outlook is uncertain due to macroeconomic factors and extended sales cycles. Despite short-te
FRAMINGHAM, Mass., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced
Definitive Healthcare Corp. (NASDAQ:DH ) Q2 2023 Results Conference Call August 14, 2023 5:00 PM ET Company Participants Matt Ruderman - Chief Legal Officer Robert Musslewhite - Chief Executive Office
Medical Product companies' results are likely to reflect base business recovery on a year-over-year basis. Let's see how NEOG, PDCO and DH are poised ahead of their earnings release.
Definitive Healthcare Corp. (DH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
FRAMINGHAM, Mass., July 13, 2023 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced t
Zacks Medical Info Systems industry stocks like Definitive Healthcare (DH), Clover Health Investments (CLOV) and Augmedix (AUGX) are expected to gain from new normal trends.
Definitive Healthcare Corp. is a leader in the healthcare commercial intelligence market, providing comprehensive data and insights for the industry with a potential market opportunity of $10 billion.
FRAMINGHAM, Mass., May 31, 2023 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced th
Definitive Healthcare Corp. (NASDAQ:DH ) Q1 2023 Earnings Conference Call May 4, 2023 5:00 PM ET Company Participants Matt Ruderman – Chief Legal Officer Robert Musslewhite – Chief Executive Offic
Definitive Healthcare Corp. (DH) came out with quarterly earnings of $0.06 per share, beating the Zacks Consensus Estimate of $0.05 per share. This compares to earnings of $0.05 per share a year ago.
FRAMINGHAM, Mass., April 24, 2023 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced
Accurately identifying toxic stocks and getting rid of them at the right time can protect your portfolio. You should sell ANGO, DH, CWST and EVA.
Similar to identifying stocks with growth potential, pinpointing toxic stocks and discarding them at the right time is the key to avoid losses. CSGP, DH, MNTK and WEST are few toxic stocks you should
Definitive Healthcare Corp. (NASDAQ:DH ) Q4 2022 Earnings Conference Call February 23, 2023 5:00 PM ET Company Participants Matt Ruderman - General Counsel Robert Musslewhite - CEO Jason Krantz - Chai
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE